| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |